Patents Assigned to Lincoln University
  • Patent number: 11690374
    Abstract: The invention provides isolated Erwinia persicina strains with activity against: a) at least one Xanthomonas species, and/or b) at least one Brassicaceae pathogen. In particular the invention provides the isolated E. persicina strains deposited as DSM 32302, DSM 32304, DSM 32305 and DSM 32303. The invention provides compositions comprising one or more strains of the invention. The invention also provides methods of use of one or more strains or compositions of the inventions to control plant pathogens, particularly Xanthomonas campestris pv. campestris.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: July 4, 2023
    Assignee: Lincoln University
    Inventors: John Graham Hampton, Eline Van Zijll De Jong
  • Patent number: 11578013
    Abstract: Nitrification inhibitors and uses of same to prevent nitrate leaching or nitrous oxide emissions as well as increase pasture or crop production. The nitrification inhibitors and formulations including same may be used for direct or indirect application to soil or pasture.
    Type: Grant
    Filed: February 4, 2022
    Date of Patent: February 14, 2023
    Assignee: Lincoln University
    Inventors: Andriy Podolyan, David Rennison, Gregory Cook, Hong Jie Di, Keith Craig Cameron, Margaret Anne Brimble, Scott Ferguson, Robert Starr Ronimus, Vincenzo Carbone
  • Publication number: 20190343125
    Abstract: The invention provides isolated Erwinia persicina strains with activity against: a) at least one Xanthomonas species, and/or b) at least one Brassicaceae pathogen. In particular the invention provides the isolated E. persicina strains deposited as DSM 32302, DSM 32304, DSM 32305 and DSM 32303. The invention provides compositions comprising one or more strains of the invention. The invention also provides methods of use of one or more strains or compositions of the inventions to control plant pathogens, particularly Xanthomonas campestris pv. campestris.
    Type: Application
    Filed: August 3, 2017
    Publication date: November 14, 2019
    Applicant: Lincoln University
    Inventors: John Graham HAMPTON, Eline VAN ZIJLL DE JONG
  • Patent number: 10004236
    Abstract: The invention provides isolated Brevibacillius laterosporus strains with insecticidal activity against at least one Lepidopteraspecies and at least one Dipteraspecies. In particular the invention provides the isolated B. laterosporus strains NMI No. V12/001946, NMI No. V12/001945 and NMI No. V12/001944. The invention provides compositions comprising one or more strain of the invention. The invention also provides methods of use of one or more strains or compositions of the inventions to control pests, particularly insect pests.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 26, 2018
    Assignee: Lincoln University
    Inventors: Travis Robert Glare, John Graham Hampton, Murray Paul Cox, Damian Alexander Bienkowski
  • Patent number: 9434762
    Abstract: The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: September 6, 2016
    Assignees: UNIVERSITY OF CANTERBURY, LINCOLN UNIVERSITY, DOUGLAS PHARMACEUTICALS LIMITED
    Inventors: Andrew David Abell, James Morriss Coxon, Matthew Alan Jones, Stephen Brian McNabb, Axel Thomas Neffe, Steven Geoffrey Aitken, Blair Gibb Stuart, Janna Marie Nikkel, Joanna Kimberley Duncan, Mutita Klanchantra, James David Morton, Roy Bickerstaffe, Lucinda Jane Goodricke Robertson, Hannah Yun Young Lee, Matthew Stewart Muir
  • Publication number: 20140194362
    Abstract: The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.
    Type: Application
    Filed: March 12, 2014
    Publication date: July 10, 2014
    Applicants: Lincoln University, Douglas Pharmaceuticals Limited, Canterprise Limited
    Inventors: Andrew David Abell, James Morriss Coxon, Matthew Alan Jones, Stephen Brian McNabb, Axel Thomas Neffe, Steven Geoffrey Aitken, Blair Gibb Stuart, Janna Marie Nikkel, Joanna Kimberley Duncan, Mutita Klanchantra, James David Morton, Roy Bickerstaffe, Lucinda Jane Goodricke Robertson, Hannah Yun Young Lee, Matthew Stewart Muir
  • Patent number: 8710178
    Abstract: The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: April 29, 2014
    Assignees: Lincoln University, Canterprise Limited, Douglas Pharmaceuticals Limited
    Inventors: Andrew David Abell, James Morriss Coxon, Matthew Alan Jones, Stephen Brian McNabb, Axel Thomas Neffe, Steven Geoffrey Aitken, Blair Gibb Stuart, Janna Marie Nikkel, Joanna Kimberley Duncan, Mutita Klanchantra, James David Morton, Roy Bickerstaffe, Lucinda Jane Goodricke Robertson, Hannah Yun Young Lee, Matthew Stewart Muir
  • Patent number: 8394623
    Abstract: The present invention relates to Trichoderma atroviride strains and their use as biological control agents or plant growth promoters. Methods and compositions for biological control of soil borne plant pathogens, and increasing plant yield using T. atroviride are also provided.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: March 12, 2013
    Assignee: Lincoln University
    Inventor: Alison Stewart
  • Publication number: 20110009260
    Abstract: The present invention relates to Trichoderma atroviride strains and their use as biological control agents or plant growth promoters. Methods and compositions for biological control of soil borne plant pathogens, and increasing plant yield using T. atroviride are also provided.
    Type: Application
    Filed: February 13, 2009
    Publication date: January 13, 2011
    Applicant: LINCOLN UNIVERSITY
    Inventor: Alison Stewart
  • Publication number: 20060089260
    Abstract: A nitrification inhibitor treatment used as a soil mangement tool on grazed pasture soils. The treatment includes the application of nitrification inhibitors in solution form and/or line particle suspension form and/or in crystalline form to treat the whole area of grazed pasture soils to: reduce nitrate leaching; reduce nitrous oxide emissions; reduce postassium, calcium and magnesium leaching; and increase pasture production in both the animal urine patch areas and non-urine patch areas. The nitrification inhibitors can be applied in conjunction with irrigation water, by a spray vehicle or in a similar way to the application of agricultural chemicals.
    Type: Application
    Filed: August 1, 2003
    Publication date: April 27, 2006
    Applicants: Lincoln University, Ravensdown Fertiliser Co-Operative Limited
    Inventors: Jie Di, Keith Cameron